Multiple Clinical Trial Analysis Shows Duloxetine Reduces Stress Urinary Incontinence Episodes and Improves Quality of Life for Women MONTE CARLO, Monaco, June 29 /PRNewswire-FirstCall/ -- Data presented today at the 3rd International Consultation on Incontinence, provide evidence for the efficacy of duloxetine, an investigational agent for the treatment of women with stress urinary incontinence (SUI). Stress urinary incontinence is an embarrassing and bothersome medical condition, which affects nearly 15 million adult women in the United States(1,2,3) and can have a significant impact on quality of life. Results from a worldwide, four-study meta- analysis, comparing the efficacy of duloxetine and placebo in more than 1,900 women, demonstrated a statistically significant improvement after 12 weeks, compared to placebo (p